WallStreetZenWallStreetZen

NASDAQ: SLS
Sellas Life Sciences Group Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SLS past revenue growth

How has SLS's revenue growth performed historically?
Company
-100%
Industry
143.99%
Market
17.8%
SLS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SLS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SLS earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$37.3M
Current Profit Margin
0%

SLS Return on Equity

Current Company
-2,405.5%
Current Industry
-63.5%
Current Market
188%
SLS's Return on Equity (-2,405.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SLS announces earnings.

SLS Return on Assets

Current Company
-241%
Current Industry
2.9%
SLS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SLS Return on Capital Employed

Current Company
496.81%
Current Industry
19.5%
SLS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SLS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SLS$0.00-$36.85M-$37.34M-100.00%N/A
RLYB$0.00-$74.41M-$74.56MN/AN/A
DTIL$48.73M-$50.83M-$61.32M+34.96%N/A
ANTX$0.00-$64.68M-$64.73MN/AN/A
ASMB$0.00-$60.75M-$61.23M-100.00%N/A
View Top Biotech Stocks

SLS earnings dates

Next earnings date
Jun 19, 2024

Sellas Life Sciences Group Earnings & Revenue FAQ

What were SLS's earnings last quarter?

On Invalid Date, Sellas Life Sciences Group (NASDAQ: SLS) reported Q4 2023 earnings per share (EPS) of -$0.25, up 41.86% year over year. Total Sellas Life Sciences Group earnings for the quarter were -$8.14 million. In the same quarter last year, Sellas Life Sciences Group's earnings per share (EPS) was -$0.43.

If you're new to stock investing, here's how to buy Sellas Life Sciences Group stock.

What was SLS's earnings growth in the past year?

As of Q2 2024, Sellas Life Sciences Group's earnings has grown year over year. Sellas Life Sciences Group's earnings in the past year totalled -$37.34 million.

What is SLS's earnings date?

Sellas Life Sciences Group's earnings date is Invalid Date. Add SLS to your watchlist to be reminded of SLS's next earnings announcement.

What was SLS's revenue last quarter?

On Invalid Date, Sellas Life Sciences Group (NASDAQ: SLS) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Sellas Life Sciences Group's revenue was $0.00.

What was SLS's revenue growth in the past year?

As of Q2 2024, Sellas Life Sciences Group's revenue has grown -100% year over year. This is 243.99 percentage points lower than the US Biotechnology industry revenue growth rate of 143.99%. Sellas Life Sciences Group's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.